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Summary
A detailed investigation of the one-pot synthesis of
[NEt4]2[MX3(CO)3] [M = Tc (1a) or Re (1b); X =
Cl), Br)] is presented. The intermediates [NEt4][Tc2-
(l-Cl)3(CO)6] (2a), [NBu4][Tc3(l3-H)(l-H)3(CO)9] (3)
and [Tc3(l-H)3(CO)12] (4) have been isolated and
characterized. The X-ray structure of (2a) is described.
Complex (2a) crystallizes in the monoclinic space group
P21/c with a = 19.491(6), b = 18.323(2) and
c = 17.497(9) A˚, and b = 97.59(2)°. Quantitative con-
version of (2a), (3) and (4) into the aqua-ion
[M(OH2)3(CO)3]
+ [M = Tc (5a) or Re (5b)] is de-
scribed. To evaluate an optimal and simple chelating
group for the ‘‘fac-M(CO)3’’ moiety, the reaction with
the bidentate thioether ligand Cl(CH2)2S(CH2)2S(CH2)2-
Cl (qyp) has been investigated and the structure of the
neutral complex [ReBr(qyp)(CO)3] (6) is described.
Complex (6) crystallizes in the monoclinic space group
P21/c with a = 15.935(6), b = 2.788(4) and c =
7.955(10) A˚, and b = 98.57(1)°. To extend the know-
ledge about substitution chemistry of organometallic
complexes in aqueous solution, the acetato ligand
[OOCCH3]
) has been reacted with (1b), resulting in the
formation of the dinuclear, acetato-bridged complex
[NEt4][Re2(l-OH)2(l-OAc)(CO)6], which converted into
[Re2(l-OEt)2(l-OAc)(CO)6]
) (7) after recrystallization
from EtOH. The X-ray structure of (7) has been de-
termined. Complex (7) crystallizes in the monoclinic
space group P21/c with a = 16.288(3), b = 12.4272(10)
and c = 13.620(3) A˚, and b = 76.63(1)°. For a future
application of the small ‘‘fac-M(CO)3’’ moiety, it seems
thus advantageous to combine these two ligand groups
in one simple chelating function.
Introduction
The application of metal complexes with a wide variety
of radionuclides in the field of nuclear medicine has
become a major tool in diagnosis and also more recently
in therapy(1–3). Beside the potential for routine applica-
tion of various radioisotopes such as 67Cu, 105Rh or
111Ag, complexes with 99mTc or 186/188Re are in wide-
spread use or have reached the stage of preclinical
evaluation. To develop stable tailor made bifunctional
chelators, complexes or precursors linkable to small or
large biomolecules, retaining their bioactivity, is a
challenge to inorganic chemistry. A number of reviews
covering this interdisciplinary field have appeared re-
cently(4–7). The most successful approaches with Tc or
Re are focused mainly on complexes with the valency
+V, typically containing the [Tc@O]3+ moiety and
readily achieved by reducing [99mTcO4]
) with, for ex-
ample, [Sn]2+. For [186ReO4]
) more vigorous conditions
have to be used. Further attempts to achieve flexibility
and convenience, based on the [Tc@O]3+ moiety, are
based on the so-called [3+1] strategies(8–11). Three co-
ordination sites around this core are protected, whereas
the fourth site is coordinated with the biomolecule. This
approach requires only derivatization with one single
group and not with a tetradentate ligand. A further at-
tractive approach, not based on the [Tc@O]3+ moiety, is
the application of hydrazides, which can provide very
stable TcN multiple bonds. The monodentate ‘‘hynic’’
ligand is a good example of this strategy(12–14).
Whether thermodynamic or kinetically stable com-
plexes are preferable for a radiopharmaceutical ap-
plication is not yet very clear, but the potential of
inertness has impressively been demonstrated with
[99mTc(CN–R)6]+(15,16). The [
99mTc(CN–R)6]
+ complex-
es are rare examples where radioactive organometallic
compounds have been applied successfully, and several
inactive investigations have demonstrated the potential
of homoleptic isocyanide complexes of technetium(I)
and rhenium(I)(17–20). Application of organometallics
suers from a drawback, namely that most of potential
precursors are prepared form [MBr(CO)5]. To avoid
[MBr(CO)5], we have developed a one-pot synthesis of
the d6 precursor [MX3(CO)3]
2) directly from [MO4]
)
under ambient conditions. The halides are labilized by
the trans standing COs and are easily exchanged by
incoming ligands. Both (1a) and (1b) form
[M(OH2)3(CO)3]
+ readily in water. A classical exchange
can occur with ligand groups potentially bearing a bio-
molecule (Scheme 1).
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In order to develop convenient anchor groups or
fragments, substitutions with a carboxylic acid and a
bidentate thioether ligand have been performed.
Experimental
Crystallographic studies
The selected crystals of (6), (2a) and (7) were mea-
sured on an Enraf-Nonius CAD-4 diractometer. The
unit cells were determined from 25 reflections each.
During data collection, the crystals were monitored for
decay every 100 reflections with three controls. No
decay was observed in any of the crystals. Absorption
corrections were applied from psi-scans. Additional
relevant parameters for crystal data, data collection,
structure solution and refinement are given in Table 1,
and important bond lengths and angles in Table 2.
[NBu4][Tc2(l-Cl)3(CO)6] (2a)
A 1 M BH3 á THF solution (6 cm
3) was added to a THF
solution (15 cm3) of [NBu4]Cl (0.38 g, 1.36 mmol) under
N2. Subsequently, CO was bubbled and [NBu4][TcO4]
(0.19 g, 0.45 mmol) in THF (2 cm3) was added dropwise
over 15 min. The solution turned yellow after each ad-
dition but lost this colour within minutes. Stirring at r.t.
for 5 h or boiling under reflux for 1 h completed the
reaction. THF was removed by evaporation and the oily
residue dissolved in CH2Cl2 (10 cm
3). Water (5 cm3) was
added and the mixture stirred for 4 h. The organic layer
was separated and the solvent evaporated. Mixing the
residue with H2O caused precipitation of the colourless
product (yield: 0.13 g, 79%). I.r. (KBr/cm)1): 2036, 1940
and 1914 [m(CO)]; 99Tc NMR (d, [TcO4]
) in D2O = 0
p.p.m.): )965 (s, D1/2 = 25 Hz).
[NEt4][Re2(l-OC2H5)2(OAc)(CO)6] (7)
Complex (1b) (0.15 g, 0.18 mmol) was dissolved in
water (3 cm3) and Ag(OAc) (0.095 g, 0.56 mmol), dis-
solved in H2O, was added. The precipitate (AgBr) was
removed by filtration and H2O evaporated in vacuo. The
residue was dissolved in EtOH and slow diusion of
Et2O resulted in crystals (yield: 0.063 g) of X-ray quality
within a few days (75%). I.r. (KBr cm)1): 1984, 1864
and 1838 [m(CO)].
[ReBr(qyp)(CO)3] (6)
 
(1b) (0.123 g, 0.16 mmol) was dissolved in MeOH
(5 cm3) and qyp (0.035 g, 0.16 mmol) added. The solu-
tion was stirred over night at r.t., the solvent evaporated
in vacuo and the waxy residue obtained stirred with Et2O
to form a crystalline solid. The solvent was separated
and the product extracted from [NEt4]Br with THF.
Slow diusion of hexane yielded crystals (78 mg) of
Scheme 1. The principle of anchor groups.
Table 1. Crystal data, data collection and solution refinement parameters for the X-ray structures of [Re2(l-OEt)2(OAc)(CO)6]
) (7), [Tc2(l-Cl)3-
(CO)6]
) (2a) and [ReBr(qyp)(CO)3] (6)
a
(7) (2a) (6)
Crystal data
Formula C20H33NO10Re2 C22H36Cl3NO6Tc2 C9H12BrCl2O3S2Re
M (g/mol) 819.87 712.87 569.32
Crystal system monoclinic monoclinic monoclinic
Space group (Nr.) P21/c (14) P21/c (14) P21/c (14)
a (A˚) 16.228(3) 19.491(6) 15.935(6)
b (A˚) 12.4272(10) 18.323(2) 2.788(4)
c (A˚) 13.620(3) 17.497(9) 7.955(10)
b (°) 76.63(1) 97.59(2) 98.57(1)
V (A˚
3
) 2672.3(8) 6194(4) 1602(2)
Z 4 8 4
qcalc (g cm
)3) 2.038 1.529 2.359
l, (mm)1) 9.100 1.184 10.663
F(000) 15600 2880 1064
Data collection
2h range (°) 3.04–28.92 3.06–25.00 3.04–26.98
h,k,l )22/21; 0/16; )18/1 )24/24; )2/0; )1/22 )19/19; )16/0; )1/10
Nr. of reflections 7910 12029 4085
Independent reflections 7079 10888 3356
Rint (%) 2.24 1.3356 2.43
Observed reflections [I>2r(I )] 5877 8553 2860
Structure solution and refinement
Goodness of fit (GooF) 1.162 1.076 1.149
R1 (%) 3.4 4.79 2.77
wR2 (%) 8.0 12.48 5.80
Rest electron density (e A˚)3) 2.125; )1.371 1.273; )0.808 1.297; )1.356
a Details in common: diractometer, CAD 4 Enraf-Nonius; radiation, MoKa k = 0.70930 A˚; graphite monochromator; absorption correction, psi
scans; temperature, 203(2) K.
 Caution! qyp Is a blister-causing vessicant.
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X-ray quality (86%). I.r. (KBr/cm)1): 2032, 1942, 1908
and 1892 [m(CO)].
Results and discussion
Low-pressure carbonylation
The synthesis of (1a) and (1b) is one of the rare ex-
amples where a low-valent carbonyl complex is prepared
directly from its permetallate(21,22). Although the overall
process includes a 6e) reduction, no defined compounds
in the intermediate oxidation states could be trapped. As
is evident from reactions with [188ReO4]
), however, the
dierent end-products were convertable into (5) by acid
or alkaline hydrolysis. In order to elucidate the nature of
these products, similar reactions were performed with
[99TcO4]
). Scheme 2 depicts the products characterized
by X-ray structure or chemical analysis.
Performing the reaction in THF in the presence of
halide yielded, as a direct precursor of (1a), the di-
nuclear complex (2a). Complex (1a) remained in solu-
tion due to the presence of the [NBu4]
+ counter-ion.
Isolation of (2a) was successful due to its insolubility in
H2O. Complex (1a) can be precipitated by addition of
[NEt4]
+ and (2a) is slowly converted into (1a) by
cleaving the Cl) bridges and subsequent precipitation
with [NEt4]Cl in EtOH. The structure of (2a) was
elucidated and an ORTEP presentation is given in
Figure 1. The Re analogue was already known from the
standard approach, starting with [Re2(CO)10]
(23).
The reaction with [188ReO4]
) gave no unambiguous
evidence for the identity of one of the byproducts with
(2a). For this reason the reaction was performed with
99Tc in the absence of halide in order to mimic the very
small halide concentration with 188Re. By this approach
the two carbonyl hydride complexes [TcH(CO)4]3 (4)
Table 2. Important bond lengths (A˚) and angles (°) in the complexes (7), (2a) and (6)
(7) (2a) (6)
Bond lengths
Re(1)AC(3) 1.886(6) Tc(1)AC(1) 1.904(8) ReAC(10) 1.979(6)
Re(1)AC(1) 1.901(7) Tc(1)AC(2) 1.889(7) ReAC(20) 1.936(6)
Re(1)AC(2) 1.901(7) Tc(1)AC(3) 1.884(7) ReAC(30) 1.917(11)
Re(1)AO(10) 2.100(4) Tc(1)ACl(3) 2.520(2) ReAS(2) 2.525(3)
Re(1)AO(20) 2.111(4) Tc(1)ACl(1) 2.5477(13) ReABr(1) 2.6087(10)
Re(1)AO(31) 2.176(4) Tc(1)ACl(2) 2.506(2) ReAS(1) 2.537(2)
Re(2)AC(5) 1.886(8) Tc(2)AC(4) 1.891(8)
Re(2)AC(4) 1.886(6) Tc(2)AC(5) 1.891(9)
Re(2)AC(6) 1.898(7) Tc(2)AC(6) 1.895(8)
Re(2)AO(32) 2.169(4) Tc(2)ACl(1) 2.5658(13)
Re(2)AO(20) 2.117(4) Tc(2)ACl(2) 2.503(2)
Re(2)AO(10) 2.114(4) Tc(2)ACl(3) 2.520(2)
Bond angles
Re(1)AO(20)ARe(2) 105.7(2) C(1)ATc(1)ACl(1) 96.3(2) C(10)AReAS(1) 173.2(2)
Re(1)AO(10)ARe(2) 106.3(2) C(1)ATc(1)ACl(2) 93.3(2) C(20)AReAS(1) 89.0(2)
O(20)ARe(1)AO(31) 81.6(2) C(1)ATc(1)ACl(3) 173.5(2) C(30)AReAS(1) 96.1(2)
O(10)ARe(1)AO(31) 82.1(2) C(2)ATc(1)ACl(2) 95.2(2) C(10)AReAS(2) 92.8(2)
C(3)ARe(1)AO(10) 98.8(2) C(2)ATc(1)ACl(3) 93.4(2) C(20)AReAS(2) 175.2(2)
C(1)ARe(1)AO(10) 99.3(2) C(3)ATc(1)ACl(1) 93.6(2) C(30)AReAS(2) 90.2(3)
C(2)ARe(1)AO(10) 171.0(2) C(3)ATc(1)ACl(2) 175.4(3) C(10)AReABr(1) 90.6(2)
O(10)ARe(1)AO(20) 73.7(2) C(3)ATc(1)ACl(3) 97.9(3) C(30)AReABr(1) 177.3(2)
C(1)ARe(1)AO(20) 172.7(2) Cl(2)ATc(1)ACl(1) 81.93(5) C(20)AReABr(1) 87.4(2)
C(2)ARe(1)AO(20) 99.6(2) Cl(2)ATc(1)ACl(3) 80.43(6) S(2)AReAS(1) 86.17(8)
C(3)ARe(1)AO(20) 97.6(2) Cl(3)ATc(1)ACl(1) 81.19(5)
C(3)ARe(1)AO(31) 178.7(2) Tc(1)ACl(1)ATc(2) 81.55(4)
C(1)ARe(1)AO(31) 95.4(2) Tc(2)ACl(2)ATc(1) 83.63(5)
C(2)ARe(1)AO(31) 91.0(2) Tc(2)ACl(3)ATc(1) 82.98(5)
Scheme 2.General conditions to prepare TcI-carbonyl precursors: (i) CO (1 atm), THF, BH3 áTHF, 30–50 °C; (ii) NaOH/MeOH r.t.; (iii) 1 M HCl/
H2O; (iv) CO (1 atm), THF, BH3 áTHF, [NBu4]Cl, 30–50 °C; (v) ex. [NEt4]Cl, EtOH.
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and [NBu4][Tc3(l-H)3(l3-H)(CO)9] (3) were isolated.
Complex (4) was characterized by X-ray structure
analysis, and (3) by spectroscopic methods(24). Complex
(3) exhibits a single resonance in the 99Tc-n.m.r. spec-
trum at )1006 p.p.m. (relative to [TcO4]
) in D2O), a
typical ‘‘fac-M(CO)3’’ pattern at 2023 and 1924 cm
)1,
two singlets in the 1H-n.m.r. and an additional set of
[NBu4]
+ signals in the correct ratio. The nature of the
two byproducts containing 188Re allowed us to develop
a strategy for their conversion into (1b) and hence into
(5b), which is a base suitable for further coordination
chemistry studies. The same procedure, as with 188Re, is
also possible with 99mTc. The reaction occurred in the
latter case much faster and radiolysis, as observed with
higher 188Re activities, did not lead to decomposition.
We conclude ultimately that this synthesis of low
valent Re- and Tc-carbonyls will open the way to their
application in nuclear medical fields.
Substitution of (5a) and (5b) with acetate and qyp
The aquo-ions (5a) and (5b), or the correspondingly
solvated complexes, e.g. with methanol, have several
distinct advantages over the usual precursors. In contrast
to [MO(gluco)], for example, they are stable over a long
period without the necessity of multidentate stabilizing
ligands such as glucoheptonate or citrate and only
monodentate solvent ligands such as H2O or MeOH
have to be substituted, which are additionally labilized
by the trans CO ligands. Although a wide variety of
complexes containing the ‘‘fac-M(CO)3’’ moiety are
known, hardly any resulted from ligand exchange based
on solvent equilibrium, but instead from CO release in
[MX(CO)5] at high temperature in non-coordinating
solvents. It was thus necessary to study such reactions to
investigate the kinetics and thermodynamics of complex
formation. We have already described the reaction with
thiols, isocyanides and aromatic or aliphatic amines in
this respect(21,22,25). For the design of anchor groups, the
two aspects of charge and softness have to be considered.
The d6 systems of group 7 transition elements are gen-
erally characterized as soft, resulting in a preference for
soft ligand atoms, e.g. thioethers or isocyanides. The
strong p-backbonding of the CO ligands results in elec-
tron deficiency and an enhanced preference for weak
donating ligands such as carboxylic acids or amines can
be expected. The concerted donating/accepting proper-
ties of dierent atoms is highly important in designing an
optimal anchor ligand.
The ligand Cl(CH2)2S(CH2)2S(CH2)2Cl (qyp) has
been chosen since it oers two moderately donating
thioether functions that are easily derivatized at the non-
coordinating terminal chlorides. The monopositive
charge of (5a) or (5b) is expected to be neutralized by
Cl) present, in particular, in aqueous solution.
The reaction of qyp with (1b) in methanol, present as
[Re(HOMe)3(CO)3]
+, was straightforward but slow. As
evident from i.r. spectroscopy, [Re(HOMe)qyp(CO)3]
+
formed initially, followed by Br) substitution of the
last MeOH, resulting in the neutral complex [ReBr-
(qyp)(CO)3] (6). An ORTEP presentation of the com-
plex molecule is given in Figure 2.
Similar behaviour was observed in water. The ease of
product formation with bidentate thioether groups
make them versatile as anchor groups for biomolecules,
since their preparation and derivatization is also con-
venient. The reaction with [Re(HOMe)3(CO)3]
+ oc-
curred at a reasonable rate (t1/2 = ca. 30 min) and
under controlled conditions. Preliminary investigations
at the n.c.a. level revealed that ligand concentration can
be decreased to an almost stochiometric level, which
represents significant progress from the above-men-
tioned protocols.
The carboxylato group is a typical anionic ligand,
able to provide dierent modes of coordination. Alone
or in combination with other groups, it is advantageous
for our purposes in two respects. The monopositive
charge of [M(Sol)3(CO)3]
+ is neutralized and additional
electron density is shifted to the metal centre, supporting
p-backbonding and inertness in combination with other
ligand groups. It is easily included in a potential bi-
dentate ligand for the same purposes, thus resulting in a
simple, probably even naturally occurring, anchor
group. To obtain fundamental information we have in-
vestigated the coordinative properties of ethanoic acid
in water. The halides were previously precipitated with
three equivalents of Ag(OAc). I.r. spectroscopic in-
vestigations in water revealed the formation of a neutral
or anionic species as evident from the redshift of the CO
stretching vibrations. T.l.c. showed the formation of a
single species. This complex could be isolated and, after
recrystallization from ethanol, structurally character-
ized. An ORTEP presentation of [NEt4][Re2(l-OEt)2-
(OAc)(CO)6] (7) is given in Figure 3. The acetato group
Figure 1. ORTEP presentation of the complex anion [Tc2(l-Cl)3-
(CO)6]
) (2a). Thermal ellipsoids are drawn on the 30% level.
Figure 2. ORTEP presentation of the complex [ReBr(qyp)(CO)3].
Thermal ellipsoids are drawn on the 30% level.
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acts as a bridging ligand between two Re centres to form
a dinuclear complex. Two bridging ethanolato ligands
occupy the remaining coordination sites.
After isolation from aqueous media, a sharp OAH
stretching vibration could be detected. Recrystallization
from ethanol resulted in the substitution of (l-OH)
groups by the corresponding alcoholato functions
without touching the acetato ligand. Potentiometric ti-
tration of (1b) in water yielded the tri- and dinuclear
species [Re3(l-OH)3(l3-OH)(CO)9]
) and [Re2(l-OH)3-
(CO)6]
)(26), respectively. It was obvious from those
experiments that the hard 2e) donating ligand [OH])
tends to form bridges between metal centres. The
‘‘fac-M(CO)3’’ moiety is not able to accept the provided
high-electron density from a single ligand, but tries to
distribute the charge over dierent cations. The same
behaviour was found to be true with the much weaker
donating acetato group and only bridging allowed co-
ordination to the ‘‘fac-M(CO)3’’ moiety. Since acetate
can act as a OH) source the remaining positions are
predominantly occupied by this ligand. From these ob-
servation carboxylato groups are not very convenient as
single ligands. Ligands have to include other groups of
backbonding properties that provide chelation to the
metal centre. Reaction of (5a) or (5b) in water with
picolinic acid, for example, did not result in a bridged
species but in the formation of a mononuclear complex
of composition [ReBr(pic)(CO)3], exhibiting exceptional
stability towards acid(25).
Conclusion
The synthesis of (1a) or (1b) from [TcO4]
) or [ReO4]
)
under 1 atm of CO at ambient temperature is an im-
portant step towards the application of organometallic
complexes in nuclear medicine. It is possible to prepare
these precursors on the n.c.a. as well as on the macro-
scopic level. Since (1a) and (1b) are converted into the
‘‘semi-aquo-ions’’ (5a) and (5b), simple ligand ex-
change reactions with easily available anchor groups can
be performed. Owing to their ‘‘soft’’ nature, ligands such
as thioethers are preferred as exemplified by the syn-
thesis of (6). Single carboxylato groups such as acetate
were shown to bridge two metal centres. Thus, single
carboxylato groups seemed not to be particularly ad-
vantageous since one ‘‘fac-M(CO)3’’ moiety can not
accept the high-electron density provided by acetate.
The fact that the carboxylate is able to coordinate to the
soft ‘‘fac-Re(CO)3’’ moiety mirrors, however, its use-
fulness in combination with other ligand groups, i.e.
those derived from thioether functions.
Supporting material
Complete information about crystal data, data collec-
tion, structure solution and refinement and tables of
bond lengths, bond angles, positional and thermal pa-
rameters of compounds (2a), (6) and (7) have been
deposited with the Editor.
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Figure 3. ORTEP presentation of the complex anion [Re2(l-OEt)2-
(OAc)(CO)6]
). Thermal ellipsoids are drawn on the 30% level.
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